Results 261 to 270 of about 70,002 (313)
Some of the next articles are maybe not open access.
Journal of Internal Medicine, 2023
To explore the role of peripheral lymphocyte count in phenotyping and prognosis prediction in dermatomyositis (DM) patients with anti‐MDA5 antibodies.
Qiwen Jin +12 more
semanticscholar +1 more source
To explore the role of peripheral lymphocyte count in phenotyping and prognosis prediction in dermatomyositis (DM) patients with anti‐MDA5 antibodies.
Qiwen Jin +12 more
semanticscholar +1 more source
Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature.
Rheumatology, 2023OBJECTIVE Among specific autoantibodies in dermatomyositis, the anti-SAE antibody is rare. We aim to describe clinical characteristics, cancer prevalence, and muscle pathology of anti-SAE positive dermatomyositis.
Juliette Demortier +32 more
semanticscholar +1 more source
Arthritis & Rheumatology, 2022
There is substantial heterogeneity among the phenotypes of patients with anti–melanoma differentiation–associated gene 5 antibody–positive (anti‐MDA5+) dermatomyositis (DM), hindering disease assessment and management.
Lingxiao Xu +27 more
semanticscholar +1 more source
There is substantial heterogeneity among the phenotypes of patients with anti–melanoma differentiation–associated gene 5 antibody–positive (anti‐MDA5+) dermatomyositis (DM), hindering disease assessment and management.
Lingxiao Xu +27 more
semanticscholar +1 more source
Characteristics of dermatomyositis patients with and without associated malignancy
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021Dermatomyositis belongs to the rare idiopathic, inflammatory myositis group. A previously postulated link between some cases of dermatomyositis and malignancy has been established in recent years. Criteria suggestive of a malignancy association are still
J. Lauinger, K. Ghoreschi, S. Volc
semanticscholar +1 more source
Arthritis & Rheumatology, 2020
To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of initial serum biomarker levels.
T. Gono +17 more
semanticscholar +1 more source
To establish predictive models for mortality in patients with polymyositis/dermatomyositis–associated interstitial lung disease (PM/DM‐ILD) using a combination of initial serum biomarker levels.
T. Gono +17 more
semanticscholar +1 more source
Dermatomyositis und juvenile Dermatomyositis
Zeitschrift für Rheumatologie, 2022Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already occur in children but first onset can also be in older adulthood. Myalgia and muscle weakness can occur later in the course of the disease or even be completely absent in some forms.
Frank, Dressler, Britta, Maurer
openaire +2 more sources
Journal of the American Academy of Dermatology, 1998
Dermatomyositis is a rare inflammatory myopathy with characteristic skin manifestations and muscular weakness. The disease can be categorized as adult idiopathic, juvenile, or amyopathic dermatomyositis as well as that associated with a connective tissue disease or a malignancy.
S O, Kovacs, S C, Kovacs
openaire +2 more sources
Dermatomyositis is a rare inflammatory myopathy with characteristic skin manifestations and muscular weakness. The disease can be categorized as adult idiopathic, juvenile, or amyopathic dermatomyositis as well as that associated with a connective tissue disease or a malignancy.
S O, Kovacs, S C, Kovacs
openaire +2 more sources
Clinics in Dermatology, 2006
Dermatomyositis is one of the idiopathic inflammatory myopathies. It is characterized clinically by progressive symmetrical proximal muscle weakness and a characteristic rash. There are patients with rash who have little or no muscle disease. Although the process primarily attacks the skin and the muscles, it is a systemic disease with frequent ...
Jeffrey P, Callen, Robert L, Wortmann
openaire +2 more sources
Dermatomyositis is one of the idiopathic inflammatory myopathies. It is characterized clinically by progressive symmetrical proximal muscle weakness and a characteristic rash. There are patients with rash who have little or no muscle disease. Although the process primarily attacks the skin and the muscles, it is a systemic disease with frequent ...
Jeffrey P, Callen, Robert L, Wortmann
openaire +2 more sources

